§450.8. Continuous glucose monitors; Medicaid coverage

            A. Except as provided in Subsection B of this Section, the Louisiana Medicaid program shall provide coverage for a continuous glucose monitor for the treatment of an enrollee who has one of the following conditions:

            (1) Any type of diabetes with the use of insulin more than two times daily or evidence of level 2 or level 3 hypoglycemia.

            (2) Glycogen storage disease type 1a.

            B. To qualify for coverage pursuant to Subsection A of this Section, the enrollee shall attend regular follow-up visits with a healthcare provider at a minimum of every six months to assess the ongoing benefit of the enrollee's use of a continuous glucose monitor.

            C.(1) The Louisiana Department of Health shall implement the provisions of this Section using the most cost-effective solution available to the department.

            (2) The secretary of the department shall submit to the Centers for Medicare and Medicaid Services all state plan amendments, promulgate all rules and regulations in accordance with the Administrative Procedure Act, and take any other actions necessary to implement the provisions of this Section.

            D. For the purposes of this Section, "continuous glucose monitor" means an instrument or device, including repair and replacement parts, that is designed and offered for the purpose of measuring glucose levels at set intervals by means of a small electrode placed under the skin and held in place by an adhesive.

            Acts 2022, No. 241, §1.